|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current assets: | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Investments held in Trust Account | ||||||
| Total Assets | ||||||
| Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit: | ||||||
| Current liabilities: | ||||||
| Accounts payable | ||||||
| Accounts payable - related party | ||||||
| Accrued expenses | ||||||
| Due to related party | ||||||
| Franchise tax payable | ||||||
| Total current liabilities | ||||||
| Convertible note – related party | ||||||
| Derivative warrant liabilities | ||||||
| Deferred underwriting commissions | ||||||
| Total liabilities | ||||||
| Class A common stock subject to possible redemption; $0.0001 par value, 20,650,000 shares at redemption value of $10.00 per share as of March 31, 2022 and December 31, 2021 | ||||||
| Stockholders’ Deficit: | ||||||
| Class A common stock, 0.0001 par value; 380,000,000 shares authorized; no non-redeemable shares issued or outstanding | ||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,162,500 shares issued and outstanding as of March 31, 2022 and December 31, 2021 | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total stockholders’ deficit | ||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
Loading...
